NASDAQ: AUPHAurinia Pharmaceuticals Inc Stock Ownership - Who owns Aurinia Pharmaceuticals?
Insider buying vs selling
Have Aurinia Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Stephen P. Robertson | CLO | 2026-09-10 | 11,939 | $15.95 | $190.43kSell |
| Stephen P. Robertson | CLO | 2026-08-21 | 20,975 | $16.97 | $355.95kSell |
| Kevin Tang | Chief Executive Officer | 2026-06-02 | 206,005 | $15.28 | $3.15MBuy |
| Kevin Tang | Chief Executive Officer | 2026-06-01 | 343,521 | $15.28 | $5.25MBuy |
| Kevin Tang | Chief Executive Officer | 2026-06-01 | 99 | $15.34 | $1.52kBuy |
| Kevin Tang | Chief Executive Officer | 2026-05-29 | 2,299 | $15.35 | $35.29kBuy |
| Kevin Tang | Chief Executive Officer | 2026-05-29 | 262,682 | $15.31 | $4.02MBuy |
| Greg Keenan | SVP Chief Medical Officer | 2026-03-06 | 8,069 | $14.32 | $115.55kSell |
| Kevin Tang | Director | 2026-03-03 | 184,208 | $14.22 | $2.62MBuy |
| Kevin Tang | Director | 2026-03-02 | 83,561 | $14.33 | $1.20MBuy |
AUPH insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when AUPH insiders and whales buy or sell their stock.
AUPH Shareholders
What type of owners hold Aurinia Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Kevin Tang | 9.80% | 13,044,106 | $221.23M | Insider |
| Peter Greenleaf | 1.38% | 1,840,379 | $31.21M | Insider |
| Matthew Maxwell Donley | 0.51% | 680,299 | $11.54M | Insider |
| Stephen P. Robertson | 0.44% | 588,848 | $9.99M | Insider |
| Joseph M. Miller | 0.43% | 576,421 | $9.78M | Insider |
| Scott Michael Habig | 0.34% | 456,338 | $7.74M | Insider |
| Volker Knappertz | 0.24% | 319,128 | $5.41M | Insider |
| Michael Robert Martin | 0.19% | 259,162 | $4.40M | Insider |
| Greg Keenan | 0.12% | 154,449 | $2.62M | Insider |
| Michael S. Hearne | 0.09% | 116,144 | $1.97M | Insider |
AUPH vs Biotech Stocks
Aurinia Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.